Literature DB >> 3382036

Potency of succinylcholine at the diaphragm and at the adductor pollicis muscle.

C E Smith1, F Donati, D R Bevan.   

Abstract

To quantify the differential effect of succinylcholine at the diaphragm and the adductor pollicis muscle, 10 patients were studied during halothane-nitrous oxide anesthesia. Train-of-four stimulation was applied to the ulnar and phrenic nerves. The force of contraction and the electromyographic response of the adductor pollicis were measured and compared with the diaphragmatic electromyogram. Then dose-response curves for both muscles were constructed using incremental doses of succinylcholine with an infusion to replace metabolized or redistributing drug. Linear regressions were obtained between the logit transformation of neuromuscular blockade at the adductor pollicis and diaphragm and the logarithm of the dose. The diaphragm was relatively resistant to succinylcholine. At 90% adductor pollicis block, the diaphragm was only (mean +/- SEM) 37 +/- 3% blocked. The diaphragm required 1.8 +/- 0.2 times as much succinylcholine as the adductor pollicis for an identical 90% block. The ED50 and ED90 values for succinylcholine at the diaphragm were 0.23 +/- 0.04 and 0.40 +/- 0.09 mg/kg, respectively. Corresponding values for the adductor pollicis were 0.14 +/- 0.01 and 0.21 +/- 0.02 mg/kg. The data indicate that the degree of adductor pollicis blockade might overestimate the intensity of diaphragmatic paralysis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382036

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  The role of the amino acid residue at alpha1:189 in the binding of neuromuscular blocking agents to mouse and human muscle nicotinic acetylcholine receptors.

Authors:  P G Purohit; R J Tate; E Pow; D Hill; J G Connolly
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

2.  Duration of succinylcholine and vecuronium blockade but not potency correlates with the ratio of endplate size to fibre size in seven muscles in the goat.

Authors:  C Ibebunjo; C B Srikant; F Donati
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

Review 3.  Monitoring neuromuscular function in the intensive care unit.

Authors:  J Viby-Mogensen
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

4.  Comparison of respiratory sparing effect between pancuronium and three new nondepolarizing muscle relaxants in rats.

Authors:  Misato Kaneko; Lu Hua
Journal:  J Anesth       Date:  1998-12       Impact factor: 2.078

5.  Does monitoring of post-tetanic count prevent alarms of airway pressure or visible muscle activity during intratracheal jet ventilation? A prospective study with five different neuromuscular blocking agents.

Authors:  A I Puura; M G Rorarius; P Laippala; G A Baer
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

6.  Succinylcholine and vecuronium blockade of the diaphragm, laryngeal and limb muscles in the anaesthetized goat.

Authors:  C Ibebunjo; L W Hall
Journal:  Can J Anaesth       Date:  1994-01       Impact factor: 5.063

7.  The optimal succinylcholine dose for intubating emergency patients: retrospective comparative study.

Authors:  Alaa Ezzat; Essam Fathi; Ahmad Zarour; Rajvir Singh; M Osama Abusaeda; M Magdy Hussien
Journal:  Libyan J Med       Date:  2011-07-14       Impact factor: 1.657

Review 8.  Monitoring of neuromuscular function in the clinical setting.

Authors:  D Kelly; S J Brull
Journal:  Yale J Biol Med       Date:  1993 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.